Celine M. Laumont
Victoria, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Rethinking ovarian cancer III: the past decade and future directions.
Journal: Nature reviews. Cancer
Published: February 23, 2026
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.
Journal: Research square
Published: November 19, 2025
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.
Journal: medRxiv : the preprint server for health sciences
Published: October 03, 2025
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.
Journal: Nature communications
Published: September 22, 2025
Phenotypic Characterization and Prognostic Impact of CD103+ Tissue-Resident Memory T Cells in Diffuse Large B-cell Lymphoma.
Journal: Cancer immunology research
Published: April 04, 2025
N-MYC impairs innate immune signaling in high-grade serous ovarian carcinoma.
Journal: Science advances
Published: May 15, 2024
Transposable elements regulate thymus development and function.
Journal: eLife
Published: April 18, 2024
Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer.
Journal: The Journal of clinical investigation
Published: January 31, 2024
BioCanRx Summit for Cancer Immunotherapy 2022 Proceedings.
Journal: Biochemistry and cell biology = Biochimie et biologie cellulaire
Published: October 23, 2023
Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities.
Journal: Nature reviews. Cancer
Published: March 03, 2022
IgA transcytosis: A new weapon in the immune response to cancer?
Journal: Cancer cell
Published: May 11, 2021
Last Updated: 09/26/2026